AG Mednet names Brian Zabin Vice President, Business Development
FOR IMMEDIATE RELEASE
Zabin Will Lead the Company’s Clinical Trials Corporate Development Activity
AG Mednet, the world’s largest diagnostic imaging exchange network, today announced that it has named Brian Zabin Vice President, Business Development. Zabin will implement the company’s strategy to further develop its customer base and will specifically focus on addressing the needs of clinical trial customers.AG Mednet, the world’s largest diagnostic imaging exchange network, today announced that it has named Brian Zabin Vice President, Business Development. Zabin will implement the company’s strategy to further develop its customer base and will specifically focus on addressing the needs of clinical trial customers.
“We are extremely pleased to welcome Brian on board to AG Mednet,” said Abraham Gutman, founder and CEO of AG Mednet. “We are confident that his global healthcare experience and corporate development expertise will enable AG Mednet to best address the imaging exchange challenges facing all of our customers and, especially, our clinical research organization members. Brian will be a member of the senior management team providing the most advanced and customer value-driven imaging exchange network available.”
Zabin joins AG Mednet from Boston Consulting Group, where he was a Principal in the Group’s Worldwide Healthcare and Corporate Development Practice Areas. His experience spans many Healthcare industries such as pharmaceuticals, biotech, medical devices, and disease management. Prior to that post, Zabin earned his M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology and served as a Captain in the United States Marine Corps. He is a Chartered Financial Analyst (CFA) and holds a B.S. in Mechanical Engineering from Trinity College.
“I am looking forward to helping drive increased use and access to the impressive AG Mednet network,” said Zabin. “The company’s diagnostic imaging exchange network provides faster and more secure image transport and handling than any other solution available. I think clinical research organizations, large and small, industry and academic, will benefit immensely from this service as they move to electronic image study transport and handling. The benefits of AG Mednet are clear: increased trial speed, enhanced trial efficiency and flexibility, and improved investigator site compliance – at a lower cost than today’s arduous manual or ad-hoc electronic methods. AG Mednet could be the foundation for this new clinical trial model and I am happy to join the team at this exciting time.”